Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Enliven Therapeutics (0) Acquired (1)
Tovinontrine (6 trials)
elvn-002 (1 trial)
fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)
pexidartinib (Turallo) (1 trial)
trastuzumab emtansine (kadcyla) (1 trial)
Trials (8 total)
Trial APIs (5 total)